PapersPMID:40651709
The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial.
- 01 · finding
- 1
- 02 · compound
- 1
- 03 · endpoint
- 1
- 04 · null
- 0
all-cis-docosa-4,7,10,13,16,19-hexaenoic acidWhat moved
1 findingHow to read these marks →all-cis-docosa-4,7,10,13,16,19-hexaenoic acid — increases tumour necrosis factor alpha concentration
very limitedFinding
“DHA supplementation resulted in greater increases in the plasma cytokines IFN-γ and TNF-α compared to placebo (P-interaction < .05).”
Quoted verbatim from The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trial. - Study
- RCT
- Duration
- 4 months
- Dose studied
- DHA-enriched algae, 4.4 g/day, 18 weeks
- Population
- women with breast cancer receiving neoadjuvant chemotherapy (both arms)